Mucociliary Clearance Augmenting Drugs Block SARS-Cov-2 Replication in Human Airway Epithelial Cells
“The reduction or loss of MCT by SARS-CoV-2 is expected to have consequential effects on COVID-19 illness, including accelerating or worsening descending infection of the airways, prolonged illness due to mucus plugging and risk for secondary infections."